Head and Neck Cancer-Drug Pipeline Analysis and Market Forecasts to 2016

GlobalData, the industry analysis specialist, has released its new report, "Head and Neck Cancer-Drug Pipeline Analysis and Market Forecasts to 2016". The report is an essential source of information and analysis on the global head and neck ...
By: www.chinaccm.com
 
May 12, 2010 - PRLog -- Summary
GlobalData, the industry analysis specialist, has released its new report, "Head and Neck Cancer-Drug Pipeline Analysis and Market Forecasts to 2016". The report is an essential source of information and analysis on the global head and neck cancer market. The report identifies the key trends shaping and driving the global head and neck cancer market. It also provides insights on the current competitive landscape and the emerging players expected to significantly alter the market positioning of the existing market leaders. More importantly, the report gives valuable insights on the pipeline products within the global head and neck cancer sector.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GlobalData's team of industry experts.

GlobalData estimated the global head and neck cancer market to be valued at $1,035m in 2009. It is forecast to grow by 8.3% annually for the next seven years to reach $1,809m by 2016. This growth is primarily attributed to the high incidence rate, prevalence rate and diagnosis rate of the disease and the high prescription rates of the currently approved products, as well as the development of vaccines, gene therapy and biologics across different stages of clinical trials. GlobalData has concluded that the global head and neck cancer market is moderately served with the current product options and there is significant scope available to new entrants to capture value from underserved segments. Designing a product which can improve the five-year survival rate, reduce tumor size, prevent tumor recurrence and offer a high safety profile is one of key challenges for prospective entrants to this market and could provide a significant market share for any company.  

GlobalData found that the global head and neck cancer market is becoming increasingly competitive. The unmet need in the head and neck cancer market is high and if a company wants to capture this unmet need, it will need to improve on the prevailing products' weaknesses and adverse effects.

Scope
The scope of the report includes:  
-Annualized global head and neck cancer market revenues data from 2001 to 2009, forecast forward 7 years to 2016.
-Geographies covered in this report include the US, the UK, Italy, Spain, Germany, France, and Japan.
-Pipeline analysis data providing a split across different phases, mechanism of action being developed and emerging trends. Key classes of mechanism of action include growth factor receptors, kinase targetters, drugs that target DNA, RNA and their synthesis, vaccines, gene therapies, histone deacetylase inhibitors, therapies based on cytokines and combination therapies.
-Analysis of the current and future market competition in the global head and neck cancer market. The key market players covered are Oncolytics Biotech Inc, Biovex Limited, Ym Biosciences Inc. and GlaxoSmithKline.
-Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
-Key topics covered include a strategic competitor assessment, market characterization, unmet needs and the implications for the future head and neck caner market.

Reasons to buy
The report will enhance your decision making capability. It will allow you to:
-Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
-Develop business strategies by understanding the trends shaping and driving the global head and neck cancer market.
-Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global head and neck cancer market in the future.
-Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
-Identify emerging players with potentially strong product portfolio and create effective   counter-strategies to gain competitive advantage.
-Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
-What's the next big thing in the global head and neck cancer market landscape? -Identify, understand and capitalize.



Table of Contents
1 Table of contents 3
1.1 List of Tables 5
1.2 List of Figures 5
2 Head and Neck Cancer Market: Market Characterization 6
2.1 Overview 6
2.2 Head and Neck Cancer Market Size 6
2.3 Head and Neck Cancer Market Forecast and CAGR 7
2.4 Drivers and Barriers for Head and Neck Cancer Market 8
2.4.1 Drivers for Head and Neck Cancer Market 8
2.4.2 Barriers for Head and Neck Cancer Market 9
2.5 Opportunity and Unmet Need 9
2.6 Key Takeaway 11
3 Head and Neck Cancer Market: Competitive Assessment 12
3.1 Overview 12
3.2 Strategic Competitor Assessment 12
3.3 Product Profile for the Major Marketed Products in the Head and Neck Cancer Market 13
3.3.1 Erbitux (cetuximab) 13
3.3.2 Taxotere (docetaxel) 15
3.4 Approved Gene Therapies in China 16
3.4.1 Oncorine (H101, Modified Adenovirus) 16
3.4.2 Gendicine (Recombinant Human Ad-P53) 16
3.5 Key Takeaway 17
4 Head and Neck Cancer Market: Pipeline Assessment 18
4.1 Overview 18
4.2 Strategic Pipeline Assessment 18
4.2.1 Technology Trends Analytic Framework 18
4.3 Head and Neck Cancer Therapeutics-Promising Drugs under Clinical Development 20
4.4 Molecule Profile for Promising Drugs under Clinical Development for Head and Neck Cancer 21
4.4.1 Tykerb/Tyverb (Lapatinib Ditosylate) 21
4.4.2 Reolysin 22
4.4.3 Oncovex 23
4.4.4 Nimotuzumab 24
4.5 Head and Neck Cancer Therapeutics Market-Clinical Pipeline by Mechanism of Action 25
4.6 Head and Neck Cancer Pipeline-Pipeline by Clinical Phases of Development 26
4.6.1 Head and Neck Cancer Therapeutics-Regulatory and Phase III Clinical Pipeline 27
4.6.2 Head and Neck Cancer Therapeutics-Phase II Clinical Pipeline 29
4.6.3 Head and Neck Cancer Therapeutics-Phase I Clinical Pipeline 33
4.6.4 Head and Neck Cancer Therapeutics-Preclinical Pipeline 36
4.7 Discontinued/Suspended Drugs for Head and Neck Cancer 36
4.8 Key Takeaway 36
5 Head and Neck Cancer Market: Implications for Future Market Competition 37
6 Head and Neck Cancer Market: Future Players in the Head and Neck Cancer Market 39
6.1 Introduction 39
6.2 GlaxoSmithKline (GSK) 39
6.2.1 Overview 39
6.2.2 Oncology Pipeline Products 41
6.3 Oncolytics Biotech, Inc. 42
6.3.1 Overview 42
6.3.2 Oncology Pipeline Products 42
6.4 Biovex Inc. 42
6.4.1 Overview 42
6.4.2 Oncology Pipeline Products 43
6.5 Ym Biosciences, Inc. 43
6.5.1 Overview 43
6.5.2 Oncology Pipeline Products 43
7 Head and Neck Cancer Market: Appendix 44
7.1 Market Definitions 44
7.2 Abbreviations 44
7.3 Research Methodology 45
7.3.1 Coverage 46
7.3.2 Secondary Research 46
7.3.3 Forecasting 47
7.3.4 Primary Research 50
7.3.5 Expert Panels 50
7.4 Contact Us 50
7.5 Disclaimer 50
7.6 Sources 51

List of Tables
1.1 List of Tables
Table 1:  Global  Head and Neck Cancer  Market Revenue ($m), 2001-2009 7
Table 2:  Global Head and Neck Cancer Market Revenue ($m), 2009-2016 8
Table 3:   Major Marketed Products Comparison in the Head and Neck Cancer Market, 2010 17

...

# # #

ChinaCCM.com is China's leading industry consultancy expert offering industry intelligence and research solution, ChinaCCM Market Research Centre is a research division focusing on professional market survey and industry research.
End
Source:www.chinaccm.com
Email:***@chinaccm.com Email Verified
Zip:100022
Tags:Medical, Reports, Research
Industry:Medical, Reports, Research
Location:Beijing - China



Like PRLog?
9K2K1K
Click to Share